Clinical Trial Update: Eltrombopag+hATG+CsA vs. hATG+CsA in Children With Severe AA [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating eltrombopag added to hATG+CsA versus hATG+CsA in children with severe acquired aplastic anemia; status not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Aplastic Anemia

Drugs mentioned

• CSA (cyclosporine A)
• Eltrombopag (eltrombopag)
• hATG (anti-thymocyte globulin)

Snippet

Sponsor: Federal Research Institute of Pediatric Hematology, Oncology and Immunology | Conditions: Acquired Aplastic Anemia | Phase 3 | Status: UNKNOWN